Cambridge Investment Research Advisors’s Invesco S&P 500 Equal Weight Health Care ETF RSPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.31M Sell
44,819
-2,686
-6% -$78.4K ﹤0.01% 1743
2025
Q1
$1.41M Sell
47,505
-3,466
-7% -$103K ﹤0.01% 1592
2024
Q4
$1.49M Sell
50,971
-24,217
-32% -$709K 0.01% 1570
2024
Q3
$2.42M Sell
75,188
-86,166
-53% -$2.78M 0.01% 1206
2024
Q2
$4.85M Buy
161,354
+7,254
+5% +$218K 0.02% 771
2024
Q1
$4.9M Buy
154,100
+4,915
+3% +$156K 0.02% 758
2023
Q4
$4.44M Buy
149,185
+11,455
+8% +$341K 0.02% 761
2023
Q3
$3.77M Buy
137,730
+92,590
+205% +$2.54M 0.02% 798
2023
Q2
$1.35M Buy
45,140
+6,350
+16% +$189K 0.01% 1416
2023
Q1
$1.13M Buy
38,790
+3,150
+9% +$91.8K 0.01% 1496
2022
Q4
$1.03M Sell
35,640
-260
-0.7% -$7.5K 0.01% 1497
2022
Q3
$902K Sell
35,900
-62,010
-63% -$1.56M 0.01% 1549
2022
Q2
$2.62M Buy
97,910
+67,320
+220% +$1.8M 0.01% 911
2022
Q1
$937K Sell
30,590
-560
-2% -$17.2K ﹤0.01% 1619
2021
Q4
$998K Sell
31,150
-940
-3% -$30.1K ﹤0.01% 1584
2021
Q3
$957K Sell
32,090
-450
-1% -$13.4K ﹤0.01% 1563
2021
Q2
$953K Sell
32,540
-1,510
-4% -$44.2K ﹤0.01% 1562
2021
Q1
$913K Sell
34,050
-7,940
-19% -$213K 0.01% 1490
2020
Q4
$1.1M Sell
41,990
-22,420
-35% -$586K 0.01% 1241
2020
Q3
$1.52M Sell
64,410
-16,960
-21% -$399K 0.01% 954
2020
Q2
$1.81M Sell
81,370
-9,940
-11% -$221K 0.01% 820
2020
Q1
$1.73M Sell
91,310
-8,810
-9% -$167K 0.02% 731
2019
Q4
$2.22M Sell
100,120
-12,740
-11% -$282K 0.02% 745
2019
Q3
$2.21M Sell
112,860
-43,560
-28% -$854K 0.02% 710
2019
Q2
$3.17M Buy
156,420
+24,850
+19% +$504K 0.03% 556
2019
Q1
$2.6M Sell
131,570
-4,510
-3% -$89K 0.02% 610
2018
Q4
$2.42M Sell
136,080
-2,550
-2% -$45.3K 0.03% 568
2018
Q3
$2.86M Buy
138,630
+1,390
+1% +$28.6K 0.03% 560
2018
Q2
$2.51M Buy
137,240
+87,540
+176% +$1.6M 0.03% 568
2018
Q1
$893K Buy
49,700
+18,760
+61% +$337K 0.01% 996
2017
Q4
$556K Sell
30,940
-6,510
-17% -$117K 0.01% 1262
2017
Q3
$656K Sell
37,450
-9,620
-20% -$169K 0.01% 1072
2017
Q2
$819K Buy
47,070
+17,260
+58% +$300K 0.01% 907
2017
Q1
$477K Sell
29,810
-3,140
-10% -$50.2K 0.01% 1106
2016
Q4
$481K Buy
32,950
+4,410
+15% +$64.4K 0.01% 1032
2016
Q3
$444K Buy
28,540
+880
+3% +$13.7K 0.01% 1103
2016
Q2
$417K Buy
27,660
+2,690
+11% +$40.6K 0.01% 1022
2016
Q1
$360K Sell
24,970
-1,680
-6% -$24.2K 0.01% 1076
2015
Q4
$409K Buy
26,650
+6,550
+33% +$101K 0.01% 953
2015
Q3
$282K Sell
20,100
-44,700
-69% -$627K 0.01% 1052
2015
Q2
$1.03M Buy
64,800
+10,490
+19% +$167K 0.03% 498
2015
Q1
$843K Buy
54,310
+35,260
+185% +$547K 0.02% 564
2014
Q4
$272K Sell
19,050
-16,760
-47% -$239K 0.01% 1058
2014
Q3
$462K Buy
35,810
+4,300
+14% +$55.5K 0.01% 871
2014
Q2
$389K Buy
+31,510
New +$389K 0.01% 874